The race is on. Alzheimer's research is a dynamic field, and momentum builds each year. This site is for professional researchers and anyone interested in following the progress in research. The Alzheimer's Association has been involved in every major advancement in Alzheimer's research since the 1980's and is a leader in the global fight for a world without Alzheimer's.
Drug Lowers Levels of Alzheimer’s Protein Tau A small clinical trial shows the drug bapineuzumab lowers levels of the hallmark Alzheimer’s protein tau. But whether it will improve disease symptoms is unknown.
> New Drug Might Reduce an Alzheimer’s Marker: Study - HealthDay
March 20, 2012
DIAN Receives the Largest Research Grant in Association History The Dominantly Inherited Alzheimer’s Network (DIAN) has been awarded a nearly $4.2 million grant from the Alzheimer’s Association, the largest research grant in Association history. The grant will support the Therapeutic Trials Unit (TTU) of DIAN, enabling DIAN-TTU to move forward more quickly with innovative drug and biomarker trials in people with genetically based, young-onset Alzheimer's disease.
> Alzheimer's Association Awards Nearly $4.2 Million to Accelerate Drug Trials - Philanthropy News Digest > Press Release - Alzheimer's Association
March 15, 2012
Alzheimer’s Association Facts and Figures 2012 Alzheimer’s Association Facts and Figures is a comprehensive annual compilation of national statistics and information on Alzheimer’s and other dementias. The report conveys the impact of Alzheimer’s on individuals, families, government and the nation’s health care system. The 2012 edition reveals that health care costs for people with Alzheimer’s and other dementias are projected to reach $200 billion this year. The report includes a special feature on the challenges faced by the 800,000 Americans with Alzheimer’s who live alone. > Access the 72-page report
> How to cite Alzheimer's Association Facts and Figures 2012 - Alzheimer's Association
The Alzheimer's Association is committed to accelerating the global effort to eliminate Alzheimer's disease. We are the largest private, nonprofit funder of Alzheimer's research. We believe in the value of collaboration and are willing to imagine a time when we will have disease-modifying treatments, preventive strategies and gold-standard care for all people affected by Alzheimer's disease.
We fund — We have awarded in excess of $292 million to more than 2,000 projects over the life of our grants program.
Alzheimer's Association National Office 225 N. Michigan Ave., Fl. 17, Chicago, IL 60601
Alzheimer's Association is a not-for-profit 501(c)(3) organization.
